How big is the HbA1c testing devices market?

The global HbA1c testing devices market size was estimated at USD 2.04 billion in 2023 and is expected to reach USD 2.16 billion in 2024.

What is the HbA1c testing devices market growth?

The global HbA1c testing devices market is expected to grow at a compound annual growth rate of 6.48% from 2024 to 2030 to reach USD 3.15 billion by 2030.

Which segment accounted for the largest HbA1c testing devices market share?

North America dominated the HbA1c testing devices market with a share of 43.16% in 2023. This is attributable to increasing Incidence and prevalence of diabetes, presence of established market player and the availability of reimbursements for certain diabetes care products, including HbA1c testing devices, has significantly contributed to the market's growth in the U.S.

Who are the key players in HbA1c testing devices market?

Some key players operating in the HbA1c testing devices market include Bio-Rad Laboratories, Inc., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, HUMAN, Trinity Biotech, Menarini Diagnostics s.r.l, SAKAE CO. LTD., Ceragem Medisys Inc, and SEKISUI MEDICAL CO., LTD.

What are the factors driving the HbA1c testing devices market?

Key factors that are driving the market growth include increasing diabetes prevalence, technological advancement in clinical diagnostics, and an increasing focus on research for development of novel diagnostics in the market.